ZygoFix
Reimagining spinal fusion.
ZygoFix is headquartered in Israel, lists 1–10 employees, and has $2.0M in recorded funding across 1 round.
- Employees
- 1–10
- Business Model
- B2B
- Website
- zygofix.com
- Total Funding
- $2.0M
- Last Round
- $2.0M Series AMar 2021
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
ZygoFix is an Israeli medical device company developing zLOCK, a bendable spinal fusion implant aimed at transforming joint stabilization and fusion for surgeons and patients. The company was founded by orthopedic industry veterans, including CTO Uri Arnin — a serial spinal-implant entrepreneur holding 29 issued patents — and focuses on safe, effective, minimally invasive fixation solutions tailored to the fast-growing Ambulatory Surgery Center (ASC) market. ZygoFix is incubated by Israel's Trendlines Group and operates out of the Misgav Business Park in Israel.
Summary
ZygoFix is a Biotech company based in Israel. It lists 1–10 employees. It has raised $2.0M in total across 1 round, most recently a $2.0M Series A round in Mar 2021. Investors include OurCrowd and Peregrine Ventures.
Funding History
Mar 2021
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/zygofix"><img src="https://indexed.vc/api/badge/company/zygofix" alt="ZygoFix on Indexed.vc" width="260" height="76" /></a>